Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013

14th EMBO | EMBL Science and Society Conference: Public and Private Health – Genomics, Medicine and Society

07 Nov 2013 - 08 Nov 2013 - EBML Heidelberg, Germany

Bookmark and Share

The next EMBO | EMBL Science and Society conference will focus on how the use of genomic information may benefit individual and public health. The interdisciplinary group of speakers will present the status of genetic and genomic research and discuss the ethical, legal, economic and societal implications as well as the practical challenges of implementing new knowledge into medical care.

Ideally, widespread use of genetic tools will allow the identification of diseases before the onset of clinical symptoms, the individualisation of drug treatment, and could induce individual behavioural changes on the basis of calculated disease risk. However, many challenges remain for the successful translation of genomic knowledge and technologies into health advances, such as medicines and diagnostics. 

Some of these challenges are scientific: the relationship between genes and variants for most diseases and conditions is still not clear, nor how they interact with lifestyle and environmental factors.  Mechanisms to monitor and assess genomic medicine in comparison to current medical practices will have to be developed in order to guarantee clinical utility; health care economics will have to be considered as well. Moreover, some policy challenges need to be resolved, including concerns about privacy and confidentiality of genetic information; the regulation and standardisation of genetic tests; and the role of general practitioners in the implementation of genetic advances. Concerns about the possible impacts on society and individuals have also been raised. These and other issues will be presented and discussed during the two days of the conference. 


Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos